Neurocea Competitors and Similar CompaniesClear all
Rigel Pharmaceuticals's competitors and similar companies include CerSci Therapeutics and Terns Pharmaceuticals.
 Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  CerSci Therapeutics CerSci Therapeutics is a biotechnology company focused on delivering a new generation of non-opioid medicines. |  Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. | |
Founding Date | Founding Date 1996 | Founding Date 2015 | Founding Date 2017 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Dallas, US HQ | Locations Foster City, US HQ |
Employees | Employees 1633% increase | Employees 7 | Employees 59 |
Valuation ($) | Valuation ($) 256 m | Valuation ($) N/A | Valuation ($) 580.9 m |
Financial | |||
Net income | Net income $367m (FY, 2025) | Net income N/A | Net income ($96.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 130m | Total funding raised $ 5.7m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
CerSci Therapeutics
HQ
Dallas, US
CerSci Therapeutics is a biotechnology company focused on delivering a new generation of non-opioid medicines.
View companyTerns Pharmaceuticals
HQ
Foster City, US
Employees
59
Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases.
View company